Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Medicinal Chemistry|February 19, 2026
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer TherapyUbaldina Galli, Marianna Moro, Federica Carolina Balestrero, et al.European Journal of Medicinal Chemistry|August 11, 2019
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail groupCristina Travelli, Silvio Aprile, Daiana Mattoteia, et al.European Journal of Medicinal Chemistry|September 12, 2024
The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulatorsAngela Lamberti, Marta Serafini, Silvio Aprile, et al.Journal of Medicinal Chemistry|May 4, 2018
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin DisordersMarta Serafini, Alessia Griglio, Silvio Aprile, et al.Journal of Medicinal Chemistry|March 10, 2020
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic ActivityMarta Serafini, Enza Torre, Silvio Aprile, et al.Chemmedchem|September 1, 2017
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its ProdrugsTracey Pirali, Elisa Ciraolo, Silvio Aprile, et al.Journal of Medicinal Chemistry|October 23, 2018
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute PancreatitisBeatrice Riva, Alessia Griglio, Marta Serafini, et al.Journal of Medicinal Chemistry|July 22, 2026
Discovery of a Dual IDO1/TDO Inhibitor That Modulates Enzymatic Activity and IDO1/SHP-2 SignalingSarah Jane Rezzi, Andrea Butticè, Salvatore Villani, et al.Blood Advances|June 13, 2022
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathyCelia Cordero-Sanchez, Emanuela Pessolano, Beatrice Riva, et al.Journal of Medicinal Chemistry|February 7, 2017
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory ActivityCristina Travelli, Silvio Aprile, Reza Rahimian, et al.Pageof 6